[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Page 76108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26174]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-746]


Importer of Controlled Substances Application: Noramco Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco Inc. has applied to be registered as an importer of 
basic class(es) of controlled substance(s). Refer to Supplemental 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before December 28, 
2020. Such persons may also file a written request for a hearing on the 
application on or before December 28, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 23, 2020, Noramco Inc., 500 Swedes Landing 
Road, Wilmington, Delaware, 19801-4417, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Nabilone................................    7379  II
Phenylacetone...........................    8501  II
Opium, Raw..............................    9600  II
Poppy Straw Concentrate.................    9670  II
Tapentadol..............................    9780  II
------------------------------------------------------------------------

    The company plans to import Phenylacetone (8501), and Poppy Straw 
Concentrate (9670) to bulk manufacture other controlled substances for 
distribution to its customers. The company plans to import an 
intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol 
for distribution to its customers. In reference to drug codes 7360 
(Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to 
import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-26174 Filed 11-25-20; 8:45 am]
BILLING CODE P